Search by Drug Name or NDC
NDC 62332-0176-91 Fesoterodine Fumarate 8 mg/1 Details
Fesoterodine Fumarate 8 mg/1
Fesoterodine Fumarate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is FESOTERODINE FUMARATE.
Product Information
NDC | 62332-0176 |
---|---|
Product ID | 62332-176_d347263f-9458-4986-be65-e626f490bb3b |
Associated GPIs | |
GCN Sequence Number | 064001 |
GCN Sequence Number Description | fesoterodine fumarate TAB ER 24H 8 MG ORAL |
HIC3 | R1A |
HIC3 Description | URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT |
GCN | 99712 |
HICL Sequence Number | 035606 |
HICL Sequence Number Description | FESOTERODINE FUMARATE |
Brand/Generic | Generic |
Proprietary Name | Fesoterodine Fumarate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Fesoterodine Fumarate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 8 |
Active Ingredient Units | mg/1 |
Substance Name | FESOTERODINE FUMARATE |
Labeler Name | Alembic Pharmaceuticals Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA204973 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62332-0176-91 (62332017691)
NDC Package Code | 62332-176-91 |
---|---|
Billing NDC | 62332017691 |
Package | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-176-91) |
Marketing Start Date | 2023-01-06 |
NDC Exclude Flag | N |
Pricing Information | N/A |